PARD Insider Trading Activity and SEC Form 4 Filings
PARD insider trading summary
No open-market insider purchases or sales of Poniard Pharmaceuticals, Inc. (PARD) have been reported on SEC Form 4 in the past 12 months.
Latest PARD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 27, 2012 | Michael S Perry | President & CMO | Sell | $1K (1,599 @ $0.83) |
| Mar 27, 2012 | Michael K Jackson | Interim CFO | Sell | $214 (257 @ $0.83) |
| Feb 16, 2012 | Michael S Perry | President & CMO | Sell | $6K (6,346 @ $0.87) |
| Feb 16, 2012 | Michael K Jackson | Interim CFO | Sell | $2K (2,401 @ $0.87) |
| Apr 13, 2011 | Michael S Perry | President & CMO | Sell | $17K (45,140 @ $0.37) |
| Apr 13, 2011 | Michael K Jackson | Interim CFO | Sell | $3K (7,655 @ $0.37) |
| Jan 5, 2011 | Michael K Jackson | Interim CFO | Sell | $23K (44,816 @ $0.52) |
| Mar 25, 2010 | Ron Martell | Chief Executive Officer | Buy | $14K (10,915 @ $1.24) |
| Mar 25, 2010 | Ron Martell | Chief Executive Officer | Buy | $2K (1,200 @ $1.26) |
| Feb 8, 2010 | Michael K Jackson | Principal Accounting Officer | Sell | $6K (3,669 @ $1.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.